Basics
Description
- Bacterial illness caused by Neisseria meningitidis
- Several forms of illness may occur
- Mild meningococcemia
- Overwhelming meningococcal sepsis
- Meningococcal meningitis
- Chronic/occult meningococcemia
- Septic arthritis
- Acquired from close contact with an infected individual or an asymptomatic carrier
- Intimate kissing and cigarette smoking are independent risk factors.
Etiology
- N. meningitidis:
- Serotypes A, B, C, D, H, I, K, L, X, Y, Z, 29E, and W135
- Serotype B is most common in US
- Majority of infections caused by A, B, C, X, Y, and W135
- Bacteria attach to and enter nasopharyngeal epithelial cells.
- Bacteria spread from the nasopharynx through the bloodstream via entry of vascular endothelium.
- Most circulating meningococci are eliminated by the spleen.
- Meningococci produce an endotoxin (lipooligosaccharide):
- Involved in pathogenesis of the skin, adrenal manifestations, and vascular collapse
- Human oropharynx/nasopharynx is the only reservoir.
- Carrier usually has developed immunity to serotype-specific antibody (not immune to all serotypes):
- Age <5 yr: 1% carrier rate
- Age 20 " 40 yr: 30 " 40% carrier rate
- Lower rate of immunity in children, which is reflected by the higher rates of infection
- Most common in fall and spring
- Increased incidence in military recruits and close living conditions
- Epidemics " ages 5 " 9 yr most/earliest affected
Diagnosis
Signs and Symptoms
- "Mild " meningococcemia:
- Most common
- Preceded by upper respiratory infection
- Fever, chills, myalgias/arthralgias, malaise
- Often self-limited, resolving in several days
- Can progress to meningitis (mortality rate 2 " 10%) or overwhelming sepsis without meningitis
- Overwhelming meningococcal sepsis:
- 10% of overall meningococcemia cases
- High mortality rate (20 " 60%)
- Most deaths occur in 1st 48 hr
- Sudden onset of illness and rapid progression of clinical course
- Initial presentation may be mild:
- Mild tachycardia
- Mild tachypnea/respiratory symptoms
- Mild hypotension
- Fever, chills, vomiting, headache, rash, muscle tenderness
- Toxic appearing
- Infants: Lethargy, poor feeding, bulging fontanel
- Rash:
- Combination of purpura/ecchymosis
- May later exhibit coalescence, necrosis/sloughing of the involved skin (purpura fulminans)
- Petechiae (over skin, mucous membranes, conjunctivae) seen in 50 " 60%
- Macules
- Papules (scrapings of papules demonstrate the organism on Gram stain)
- Deteriorate quickly over several hours:
- Hypotension/shock
- Acidosis
- Acute respiratory distress syndrome (ARDS)
- Disseminated intravascular coagulation (DIC)
- Meningitis may or may not be present.
- Waterhouse " Friderichsen syndrome:
- Bilateral hemorrhagic destruction of adrenal glands
- Vasomotor collapse
- Acute renal failure:
- From prolonged hypotension (low renal perfusion causing acute tubular necrosis)
- Chronic meningococcemia:
- Uncommon
- Well appearing
- Recurrent fevers, chills, arthralgias over weeks to months
- Intermittent rash " painful on the extremities
- Migratory polyarthritis
- Splenomegaly (20%)
- Meningococcal meningitis:
- Headache
- Fever
- Neck stiffness
- Confusion
- Lethargy
- Obtundation
- Septic arthritis:
- Occurs during active meningococcemia
- Multiple joints involved
- Joint pain, redness, swelling, effusion, fever, chills
- Extremely limited or no range of motion
- Other meningococcal infections:
- Occur with meningococcal infection elsewhere
- Conjunctivitis " may occur alone
- Sinusitis
- Panophthalmitis
- Urethritis
- Salpingitis
- Prostatitis
- Pneumonia
- Myocarditis/pericarditis:
- Occurs late in onset
- Usually associated with serogroup C
History
Progression of illness is variable and classifies illness into mild, overwhelming, and chronic.
Physical Exam
- Tachycardia
- Hypotension, which may be mild initially
- Progressive, rapid deterioration
- Respiratory failure with ARDS picture
- Petechial rash 50 " 80%:
- Involves axillae, flanks, wrists, ankles
Essential Workup
- Do not allow workup (including delay in lumbar puncture) to postpone resuscitation and administration of antibiotics in suspected cases of meningococcemia.
- Suspect diagnosis in setting of dramatic clinical presentation.
- Gram stain and culture of:
- Peripheral blood, CSF, sputum, urine, joint aspirate, or petechial/papular scrapings
- Gram stain: Intracellular or extracellular gram-negative diplococci
Diagnosis Tests & Interpretation
Lab
- CBC:
- Elevated WBCs initially; later may be suppressed in severe disease
- Decreased platelet count when large areas of purpura/petechiae or DIC
- Electrolytes, BUN, creatinine, glucose
- CSF:
- Gram stain, culture, protein and glucose, cell count with differential
- Consistent with bacterial infection in meningococcal meningitis
- Arterial blood gases for acidosis, hypoxia
- Fibrinogen levels, fibrin degradation products, prothrombin time, partial thromboplastin time if DIC suspected
- Throat/nasopharyngeal swab:
- Positive swab does not establish the diagnosis of meningococcemia.
- Analysis of buffy-coat layer of peripheral blood for bacteria if sepsis is suspected
- Blood culture:
- Often negative with chronic meningococcemia
- Positive in mild and overwhelming meningococcemia
- Immunoassays (beware false negatives)
- Polymerase chain reaction, especially useful when antibiotics given before specimen collection
Imaging
CXR: For ARDS/pneumonia
Diagnostic Procedures/Surgery
Amputations and debridement of necrotic tissue and/or extremities may be necessary.
Differential Diagnosis
- Viral exanthem
- Vasculitis
- Mycoplasma
- Rocky Mountain spotted fever
- Toxic shock syndrome
- Henoch " Sch Άnlein purpura
- Idiopathic thrombocytopenic purpura
- Dengue fever
- Disseminated gonococcal infection
- Influenza
- Streptococcus group A and B
- Thrombotic thrombocytopenic purpura
Treatment
Pre-Hospital
Postexposure prophylaxis needed for pre-hospital personnel in close contact with patient
Initial Stabilization/Therapy
- Wear mask and gloves, observe droplet precautions.
- Notify department of health.
- ABCs
- Immediate endotracheal intubation for severe acidosis, hypoxia, or decreased mental status:
- Hyperventilate to treat acidosis (target PCO2 about 25 mm Hg)
- Treat hypotension:
- 0.9% normal saline bolus of 20 mL/kg; cautious rehydration with ARDS, CHF
- Begin dopamine or norepinephrine (epinephrine if no response) if hypotensive after 2 L of IV fluids.
- Naloxone, thiamine, dextrose (Accu-Chek) for altered mental status
- Initiate IV antibiotics:
- 1st line: High-dose penicillin (proven meningococcemia) or 3rd-generation cephalosporin (broader coverage pending definitive diagnosis)
- 2nd line: Ampicillin
- 3rd line: Chloramphenicol (penicillin-allergic patients)
Ed Treatment/Procedures
- Overwhelming meningococcal sepsis
- Severe acidosis (pH <7 " 7.1 or serum HCO3 <8 " 10):
- Administer IV NaHCO3 along with hyperventilation.
- Insert Foley catheter to monitor urine output.
- Place in respiratory isolation.
- High-dose steroids:
- To protect against cranial nerve injury in the setting of ongoing infection (controversial)
- Administer with adrenal gland injury.
- DIC treatment:
- Administer fresh-frozen plasma and platelet transfusions.
- Heparin is not indicated unless significant thrombotic complications are evident clinically (e.g., cyanosis or cold digits, low urine output despite adequate volume status, and blood pressure).
- Prophylaxis options for close contacts:
- Ideally, prophylaxis should be given within 1st 24 hr.
- 10-day window of observation
- Serogroup-specific vaccine as adjunct only
- Vaccine:
- Vaccine recommended in military recruits, travelers to endemic areas, complement-deficient or asplenic patients, 1st-year college dormitory residents
- Vaccine recommended routinely for ages 11 " 18 yr
The safety of meningococcal vaccine is unclear in pregnancy.
Medication
First Line
- Cefotaxime: 2 g (peds: 50 mg/kg) IV q6h
- Ceftriaxone: 2 g (peds: 50 mg/kg) IV q12h
- Penicillin G: 4 MU (peds: 250,000 U/kg/24 h) IV q4h
Second Line
- Ampicillin: 2 " 3 g (peds: 200 " 400 mg/kg/24 h) IV q6h
- Chloramphenicol: 50 " 100 mg/kg/24 h IV q6h (max. 4 g/d)
- Prophylaxis:
- Single-dose ceftriaxone:
- 125 mg IM for age <15 yr
- 250 mg IM for age >15 yr
- Ciprofloxacin: 500 mg PO (adults)
- Rifampin: 600 mg (peds: 5 " 10 mg/kg) PO BID for 2 days
- Azithromycin 500 mg PO single dose (not routinely used)
- Dexamethasone: 0.15 mg/kg IV for pediatric meningitis
- Dopamine: 5 " 20 ug/kg/min IV titrate to blood pressure (BP)
- Epinephrine: 2 " 10 ug/min IV titrate to BP
- Heparin: 3,000 " 5,000 U (peds: 80 U/kg) IV bolus followed by 600 " 1,000 U/h (peds: 18 U/kg/h) IV drip
- Hydrocortisone (Solu-Cortef): 100 mg (peds: 2 mg/kg) bolus IV for adrenal insufficiency q8h
- Meningococcal polysaccharide 0.5 mL IM 1
- Meningococcal vaccine 0.5 mL SC 1
- Norepinephrine: 0.5 " 30 ug/min IV titrate to BP
- Sodium bicarbonate: 2 " 5 mEq/kg (peds: 0.5 " 1 mEq/kg) IV over 30 min to 4 hr
Follow-Up
Disposition
Admission Criteria
- ICU admission for overwhelming sepsis with respiratory isolation
- Respiratory isolation admission for mild meningococcemia
Discharge Criteria
Prophylaxis for close patient contacts
Issues for Referral
- Consider transfer to tertiary care center, as multisystem organ failure is common.
- Late neurologic, cardiovascular, and orthopedic complications may necessitate follow-up with specialists.
Follow-Up Recommendations
- Complete antibiotic course.
- Respiratory precautions may be discontinued after 24 hr.
- All close contacts need prophylaxis.
Pearls and Pitfalls
- Notify department of health in any suspected case.
- Watch for late development of pericardial tamponade.
- Do not wait to give antibiotics.
Additional Reading
- Apicella M. Neisseria meningitidis. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Disease. 7th ed. Philadelphia, PA: Churchill Livingston Elsevier; 2010:2737 " 2752.
- Cramer JP, Wilder-Smith A. Meningococcal disease in travelers: Update on vaccine options. Curr Opin Infect Dis. 2012;25(5):507 " 517.
- Pace D, Pollard AJ. Meningococcal disease: Clinical presentation and sequelae. Vaccine. 2012;30(suppl 2):B3 " B9.
- Rosenstein R, Perkins BA, Stephens DS, et al. Meningococcal disease. N Engl J Med. 2001;344(18):1378 " 1388.
See Also (Topic, Algorithm, Electronic Media Element)
Codes
ICD9
036.2 Meningococcemia
ICD10
- A39.2 Acute meningococcemia
- A39.3 Chronic meningococcemia
- A39.4 Meningococcemia, unspecified
SNOMED
- 4089001 Meningococcemia (disorder)
- 186365005 Acute meningococcemia
- 240426001 chronic meningococcemia (disorder)